David joined Enesi Pharma in September 2017 as CEO. Prior to this role he has more than 25 years of business development and licensing experience concerning cutting-edge technologies in high growth, complex, IP-rich environments, with a prime focus on the pharmaceutical industry. Over the course of various senior executive roles in his career he has been involved in fund-raising and business growth to the tunes of hundreds of millions of pounds to the benefit of this critical sector for public health. Along with Andy Bush, David was an early supporter of Tap Social, helping us to grow to a second brewing site and open new hospitality venues to support our social impact work, and he brings his wealth of experience in business finance and growth to our Advisory Board.